These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12704736)

  • 21. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
    Spencer K; Nicolaides KH
    Prenat Diagn; 2002 Oct; 22(10):877-9. PubMed ID: 12378569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down syndrome screening in the first and second trimesters: what do the data show?
    Rosen T; D'Alton ME
    Semin Perinatol; 2005 Dec; 29(6):367-75. PubMed ID: 16533649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester.
    Madsen HN; Ball S; Wright D; Tørring N; Petersen OB; Nicolaides KH; Spencer K
    Ultrasound Obstet Gynecol; 2011 Jan; 37(1):38-47. PubMed ID: 20878678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation.
    Spencer K; Ong CY; Liao AW; Papademetriou D; Nicolaides KH
    Prenat Diagn; 2000 Aug; 20(8):673-5. PubMed ID: 10951481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study.
    Borrell A; Casals E; Fortuny A; Farre MT; Gonce A; Sanchez A; Soler A; Cararach V; Vanrell JA
    Prenat Diagn; 2004 Jul; 24(7):541-5. PubMed ID: 15300745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
    Perni SC; Predanic M; Kalish RB; Chervenak FA; Chasen ST
    Am J Obstet Gynecol; 2006 Jan; 194(1):127-30. PubMed ID: 16389021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Maternal biochemical screening -- an approach for genetic prevention. part 1. first and second trimester screening].
    Angelova L; Gadancheva V; Konstantinova D; Stoianova M; Hachmerian M; Yakov B; Kremenski I
    Akush Ginekol (Sofiia); 2013; 52(5):8-13. PubMed ID: 24501862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
    Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential triage in the first trimester may enhance advanced ultrasound scanning in population screening for trisomy 21.
    Gyselaers WJ; Roets ER; Van Holsbeke CD; Vereecken AJ; Van Herck EJ; Straetmans DP; Ombelet WU; Nijhuis JG
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):622-7. PubMed ID: 16710884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss.
    Goetzl L; Krantz D; Simpson JL; Silver RK; Zachary JM; Pergament E; Platt LD; Mahoney MJ; Wapner RJ
    Obstet Gynecol; 2004 Jul; 104(1):30-6. PubMed ID: 15228997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin.
    Yaron Y; Ochshorn Y; Tsabari S; Shira AB
    Prenat Diagn; 2004 Jun; 24(6):445-50. PubMed ID: 15229844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisited.
    Spencer K
    Prenat Diagn; 2002 Oct; 22(10):874-6. PubMed ID: 12378568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.